Perpetual Ltd Raises Position in Gilead Sciences, Inc. $GILD

Perpetual Ltd significantly increased its stake in Gilead Sciences, Inc. by 117.9% in Q4, bringing its total holdings to 28,498 shares valued at $3.498 million. The biopharmaceutical company has a “Moderate Buy” consensus rating from analysts, with a target price of $157.62, and recently raised its quarterly dividend to $0.82. Despite some insider selling, institutional investors own a substantial portion of the company’s stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments